Clover Health GC Joseph Martin resigns effective June 16, 2023 for role at another public company

CLOVER HEALTH INVESTMENTS, CORP. /DE

Joseph Martin resigns as General Counsel and Corporate Secretary, effective June 16, 2023, to join another public company.
No successor has been announced; CEO Andrew Toy praised Martin as a 'fantastic partner' during Clover's early public phase.
Martin expressed continued support for Clover's mission to improve Medicare sustainability.
Departure is voluntary; no details on interim arrangements or search for replacement provided.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Joseph Martin

General Counsel and Corporate Secretary

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Effective: 2023-06-16
Filed: June 8, 2023, 7:59 PM ET

On June 5, 2023, Joseph Martin notified Clover Health Investments, Corp. (the “Company”) that he will be resigning as General Counsel and Corporate Secretary of the Company, effective as of June 16, 2023, in order to pursue a new role at a public company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Joseph Martin departed as General Counsel and Corporate Secretary at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: resigning
Role: General Counsel and Corporate Secretary

Exact text from the filing

On June 5, 2023, Joseph Martin notified Clover Health Investments, Corp. (the “Company”) that he will be resigning as General Counsel and Corporate Secretary of the Company, effective as of June 16, 2023, in order to pursue a new role at a public company.

View on SEC.gov

CLOVER HEALTH INVESTMENTS, CORP. /DE filing history →

Source: SEC EDGAR

accession 0001801170-23-000040

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.